image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 7 days, don't miss out!

Plus500

March 2026

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • PLUS
  • Price:
  • 4768p
The shares rocketed to over £47 after Plus announced revenues of US$792m (vs US$758m forecast), materially ahead of consensus for 2025 after a strong Q4. EBITDA was slightly ahead at US$348m (forecast: US$346m). Plus has actively focused on higher value customers and average revenue per user grew 8% over the year and by 18% in Q4.  Strategically speaking, Plus has broadened and diversified its territories and product range. Over Q4 it has progressed partnerships in the US futures and prediction markets as a clearing partner for FanDuel, the sports gaming company. 2025 also saw the securing of new regulatory licences in the UAE and Canada, as well as authorisation to establish a representative office in Colombia, marking the first ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe